When Judge Richard Posner in September abruptly retired from the U.S. Court of Appeals for the Seventh Circuit, he levelled pointed criticism at his colleagues on the bench for failing to do enough to help pro se litigants. On Tuesday, his fellow Seventh Circuit judges offered something of a respons
Facing a high-stakes patent validity proceeding at the U.S. Patent and Trademark Office, pharmaceutical giant Allergan assigned the IP rights being challenged to the Saint Regis Mohawk Tribe. Because hey—sovereign immunity!
You'd like to think a lawyer would recognize when filing a lawsuit is not just ill-advised, but might actually make things worse. Or not. Case in point: Attorney Andrew Greene's libel suit against Paramount Pictures.
My parents' house in my hometown of Santa Rosa, California was saved on Wednesday by a firebreak. In some ways, Quinn Emanuel Urquhart & Sullivan name partner Kathleen Sullivan has been tasked with an analogous role for Pacific Gas & Electric in fire-related lawsuits: that is, to stop a potential co
Bellwether trials seem like such a sensible idea: let's put a few cases in front of a jury and use the results to settle the rest. Except sometimes bellwethers just make everything more confusing. The latest example: AndroGel.
A jury in San Bernardino County, California just awarded a family a record $546,000 for being bitten by bed bugs during a one-night stay at a Hilton Garden Inn. No medical bills. No property damage. Just emotional distress from the bug bites plus $50,000 in punitive damages. Say what?
In a sweet win for lead counsel James Ho, a partner at Gibson, Dunn & Crutcher who was nominated last week by President Donald Trump for a seat on the Fifth Circuit, highway guardrail maker Trinity Industries dodged a $682 million bullet. What happened?
Six months after North Face founder Doug Tompkins died, his daughter Summer Tompkins Walker quietly filed a "forced heirship" suit in Los Angeles Superior Court seeking a share of her father's assets—litigation that has not previously been reported.
Don't you hate it when you slog away through motions and discovery for months or years, only to get bumped when the client realizes (holy crap!) that this thing is going to trial? Conversely, don't you love it when you're the one who gets the call to parachute in? Both sentiments animate a new marke
In no uncertain terms, a federal judge in Manhattan dismissed with prejudice an antitrust suit by a Russian drugmaker who accused three rivals of an elaborate conspiracy to keep its biosimilar cancer drugs out of the U.S. market. It was a thorough win for a dream team of lawyers from Latham & Watkin